This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.


Affibody AB

Drug Names(s): 111-In-ABY-025, 68-Ga-ABY-025, [68]Ga-ABY025, ABY 025, ABY025

Deal Structure: ABY-025 is a second generation HER2-binding molecular imaging agent, under development for the diagnosis of breast cancer.

ABY-025 News

Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug